The National Association for Proton Therapy hosted its 2021 meeting online from April 14th-16th. Presentations ranged from open group discussions to more exclusive insights on how treatment planning strategies for proton therapy are being used in centers across the country.
Mevion hosted several NAPT sessions, including the Mevion Industry Symposium, Expanding IMPT and FLASH with Adaptive Aperture pML, and one Meet the Experts session, which featured Mevion customers who are currently using the MEVION S250i Proton Therapy System in their centers.
Watch the symposium recordings and view the session summaries for additional details:
Mevion Symposium: "Expanding IMPT and FLASH with Adaptive Aperture® pMLC."
Session summary: Mevion's Symposium focused on the clinical value and use cases from Mevion customers and exciting new FLASH and Adaptive Aperture pMLC research updates from Mevion's Advanced Development team. Dr. Unger detailed how patients are being treated at the Georgetown Lombardi Comprehensive Cancer Center at Medstar Georgetown University Hospital, and Dr. Badiyan described the advantages of proton therapy for patients and staff alike at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.
Dr. keith unger, md, MEDSTAR GEORGETOWN UNIVERSITY HOSPITAL
Dr. Shahid Badiyan, MD, Washington University, St. Louis, Barnes-Jewish Hospital
Townsend Zwart, P.h.D., Vice President of Advanced Development at Mevion
Stanley "Skip" Rosenthal, P.h.D., Senior Vice President, Clinical Affairs, Mevion
Meet the Experts: "The Evolution of the First Compact Proton Therapy Center: 8 Years On."
Session summary: Dr. Brian Baumann shared his thoughts on treatment plans inspired by what he is currently practicing at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. He also discussed IMPT trends and his thoughts on the clinical, operational, and legislative challenges for the future of proton therapy.